Kazimi A J's Form 4 filing
Cumberland Pharmaceuticals Inc (CPIX) · filed Dec 30, 2024
- Accession no.
- 0001628280-24-052606
- Filed
- Dec 30, 2024
- Trade date
- Dec 2-20, 2024
- Filing delay
- 28 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 15 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.32K. It was filed 28 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kazimi A JCIK 0001075050 | Director, Officer (Chairman and CEO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Common Stock | PPurchaseAcquired | +70 | $1.33 | +$93.1 | 5,701,597 | Direct | |
| Dec 3, 2024 | Common Stock | PPurchaseAcquired | +70 | $1.26 | +$88.2 | 5,701,667 | Direct | |
| Dec 4, 2024 | Common Stock | PPurchaseAcquired | +70 | $1.22 | +$85.4 | 5,701,737 | Direct | |
| Dec 5, 2024 | Common Stock | PPurchaseAcquired | +65 | $1.20 | +$78 | 5,701,802 | Direct | |
| Dec 6, 2024 | Common Stock | PPurchaseAcquired | +70 | $1.20 | +$84 | 5,701,872 | Direct | |
| Dec 9, 2024 | Common Stock | PPurchaseAcquired | +70 | $1.25 | +$87.5 | 5,701,942 | Direct | |
| Dec 10, 2024 | Common Stock | PPurchaseAcquired | +32 | $2.48 | +$79.36 | 5,701,974 | Direct | |
| Dec 11, 2024 | Common Stock | PPurchaseAcquired | +32 | $2.29 | +$73.28 | 5,702,006 | Direct | |
| Dec 12, 2024 | Common Stock | PPurchaseAcquired | +32 | $2.19 | +$70.08 | 5,702,038 | Direct | |
| Dec 13, 2024 | Common Stock | PPurchaseAcquired | +32 | $2.33 | +$74.56 | 5,702,070 | Direct | |
| Dec 16, 2024 | Common Stock | PPurchaseAcquired | +49 | $2.21 | +$108.29 | 5,702,119 | Direct | |
| Dec 17, 2024 | Common Stock | PPurchaseAcquired | +49 | $2.12 | +$103.88 | 5,702,168 | Direct | |
| Dec 18, 2024 | Common Stock | PPurchaseAcquired | +49 | $2.19 | +$107.31 | 5,702,217 | Direct | |
| Dec 19, 2024 | Common Stock | PPurchaseAcquired | +40 | $2.33 | +$93.2 | 5,702,257 | Direct | |
| Dec 20, 2024 | Common Stock | PPurchaseAcquired | +39 | $2.35 | +$91.65 | 5,702,296 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.